ASC Biosciences to Receive $1.5MM Funding for Stem Cell Platform

ASC Biosciences entered into a Letter Of Intent with Stem Cell Development Fund (SCDF) to receive a total of US $1.5MM in staged funding that will support operations, intellectual property development and marketing. ASC, a development stage biotechnology company, owns a proprietary platform of Multipotent Adult Stem Cells (MASCs) that...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us